Trump Targets Medicare Price Negotiations in New Executive Order
Novavax Covid Vaccine Shows Milder Side Effects Than Pfizer-BioNTech's Shot: Study
Earnings Call Summary | Johnson & Johnson(JNJ.US) Q1 2025 Earnings Conference
Tariffs Threaten Generic Drug Production and Supply - Fmr. FDA Commissioner
Johnson & Johnson Outlines $92B 2025 Sales Guidance Amid Innovative Medicine and Medtech Growth
Johnson & Johnson Q1 Earnings: Strong Cancer Drug Sales, Boosts Quarterly Dividend, Anticipates Negative Currency Impact For 2025 Profit
BC_76 : maybe the shorts are covering back their positions. It may be heavily oversold when down to below 21.
Deep Sea OP BC_76 : Agreed. Squeeze the shorts and let them cover back at higher price.
BC_76 : I hope pfizer announces shares buyback soon.
Deep Sea OP BC_76 : Hope so.